文献速递临床试验与 GCP基础与转化研究

整体调整针灸治疗绝经后骨质疏松:随机假针对照试验方案

Overall adjustment acupuncture for postmenopausal osteoporosis (PMOP): a study protocol for a randomized sham-controlled trial.
PubMed 文献 · Trials · 2020-06-03

本研究为随机、假针对照、患者与评估者盲法的试验方案,拟招募104例45-70岁绝经后骨质疏松女性,1:1分配至整体调整针灸组或假针灸组,两组均接受中药基础治疗。主要结局为骨密度,次要结局包括雌激素相关指标、骨代谢标志物、氧化应激指标、疼痛评分等,旨在评估整体调整针灸的疗效。

要点

  • 整体调整针灸对比假针灸,联合中药基础治疗,主要结局为骨密度。
  • 拟招募104例45-70岁绝经后骨质疏松女性,1:1随机分组。
  • 探索针灸通过改善雌激素水平及氧化应激下骨髓细胞成骨/成脂分化失衡的机制。

核心结论

  • 本试验旨在比较整体调整针灸与假针灸的疗效,评估其能否通过改善绝经后女性雌激素水平来防治绝经后骨质疏松。

研究设计与样本

  • 随机、假针对照、患者与评估者盲法的试验方案,拟招募104例45-70岁诊断为绝经后骨质疏松的女性。
  • 参与者按1:1比例随机分配至整体调整针灸组和假针灸组。
  • 两组均接受真实中药治疗作为基础治疗,每日两次,持续3个月。
  • 针灸治疗每周两次,持续3个月;结局在基线、治疗中期(1.5个月)和治疗结束时(3个月)收集。

关键数值与推荐

  • 主要结局为骨密度(BMD)。
  • 次要结局包括雌二醇(E2)、促卵泡激素(FSH)、骨钙素(BGP)、骨碱性磷酸酶(BALP)、总抗氧化能力(TAC)、晚期氧化蛋白产物(AOPP)、PPARγ、β-catenin、FoxO3a水平、视觉模拟疼痛评分(VAS)、中医证候评分和生活质量评分(QOL)。

临床怎么用

  • 该方案为评估整体调整针灸治疗绝经后骨质疏松的疗效与机制提供临床研究框架,结果尚未报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Osteoporosis is becoming more prevalent in aging societies worldwide, and the economic burden attributable to osteoporotic fractures is substantial. The medications presently available to treat osteoporosis have side effects. Acupuncture is widely used for treating osteoporotic postmenopausal women because it is non-invasive and has fewer side effects, but the powerful clinical evidence for its efficacy remains insufficient. Our study intends to explore the effect of overall adjustment acupuncture (OA) in the treatment of postmenopausal osteoporosis (PMOP). METHODS/DESIGN: This study is a randomized, sham-controlled, patient- and assessor-blinded trial and aims to evaluate the effect of OA in women with PMOP. We will recruit 104 women aged 45-70 years with a diagnosis of PMOP. Participants will be randomly allocated in a 1:1 ratio to the OA group and the sham acupuncture (SA) group. Both groups will receive real herbal medicine treatment as a basic treatment twice a day for 3 months, the OA group receives real acupuncture treatment and the SA group receives placebo acupuncture treatment (non-penetrating, sham skin-needle therapy, sham cupping). All patients will receive acupuncture treatment twice per week for 3 months. The primary outcome is bone mineral density (BMD) and the secondary outcomes include estradiol (E2), follicle-stimulating hormone (FSH), bone gla protein (BGP), bone alkaline phosphatase (BALP), total antioxidant capacity (TAC), advanced oxidation protein products (AOPP), PPARγ, β-catenin, FoxO3a levels, visual analog pain scale score (VAS), Traditional Chinese medicine (TCM) syndrome scores and quality of daily life score (QOL). Outcome measures will be collected at baseline, middle of the treatment (1.5 months), the end of treatment (3 months). The present protocol followed the SPIRIT guidelines and fulfills the SPIRIT Checklist. CONCLUSION: This study will be conducted to compare the efficacy of OA versus SA. This trial should help to evaluate whether OA can effectively prevent and treat PMOP by improving the estrogen levels of postmenopausal women. The mechanism is to improve the imbalance of osteogenic differentiation and lipogenesis of bone-marrow cells under oxidative stress. TRIAL REGISTRATION: Chinese Clinical Trial Registry, ID: ChiCTR1800017581. Registered on 5 August 2018. URL: http://www.chictr.org.cn.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Ren ZQ, Wang YF, Ao GF, et al. Overall adjustment acupuncture for postmenopausal osteoporosis (PMOP): a study protocol for a randomized sham-controlled trial. Trials. 2020. PMID: 32493411. doi:10.1186/s13063-020-04435-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。